A 25-gene panel predicting the benefits of immunotherapy in head and neck squamous cell carcinoma.
Huang Y, Liao J, Liang F, Lin P, Wu S, Ye Y, Gao M, Chen R, Zeng H, Yin X, Jiang Y, Ouyang N, Han P, Huang X.
Huang Y, et al.
Int Immunopharmacol. 2022 Sep;110:108846. doi: 10.1016/j.intimp.2022.108846. Epub 2022 Jul 8.
Int Immunopharmacol. 2022.
PMID: 35816946
Free article.